Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
93 Cards in this Set
- Front
- Back
how would you interpret/treat:
before breakfast = 210 before bed = 110 3 am fasting = 110 |
the is the DAWN phenomenon
it is secondary to increased GH release between 5-8 am that antagonizes insulin thus causing the early AM HYPERglycemia. Treatment is to divide the NPH dose between dinner and bedtime or change to a basal insulin |
|
treat/interpret:
before lunch = 200 |
too large of a breakfast meal or increase the dose of reg or RA insulin at breakfast
|
|
interpret/treat
before dinner = 220 |
considering diet, possibly too large a meal at lunch or increase dose of NPH at breakfast or reg or RA at lunch
|
|
T/F
Diabetes mellitus, diabetes insipidus, and psychogenic polydipsia are associated with polyuria. DM: osmotic diuresis is the cause DI and psychogenic polydipsia: the loss of free water is the cause |
True
|
|
T/F
Dysmenorrhea is most commonly due to endometriosis. |
False
it is most commonly caused by increased PGF2, which increases uterine smooth muscle contractions. Endometriosis is the most common cause of secondary dysmenorrhea |
|
T/F
There may be cross-reactivity of bovine serum albumin derived from drinking cows milk with antigens in the b-cells. hence antibodies against BSA may also destroy b-cell. |
True
|
|
T/F
Blurry vision in patients who first present with DM is most commonly due to retinopathy |
False
glucose is converted to sorbitol in the lens alters the refractive index and causes blurry vision later on retinopathy may cause blurry vision |
|
T/F
Urine dipsticks for glucose are specific for glucose and no other reducing substances. |
True
|
|
T/F
Urine dipsticks for ketones detect acetone, acetoacetate, and b-OHB. |
False
Nitroprusside does NOT detect b-OHB |
|
T/F
B-blockers block all of the adrenergic symptoms associated with insulin-induced HYOPglycemia. |
False
they do not block sweating |
|
T/F
Human insulin is less likely to result in insulin resistance due to antibodies when compared to animal derived insulins. |
True
|
|
T/F
Type II DM is more common than type I DM and has the greatest association with a positive family history |
True
|
|
Biphasic insulin release occurs with:
|
HYPERglycemia
|
|
what controls glucose levels in the fed state?
|
INSULIN
|
|
what controls blood glucose levels in the fasting state?
|
Glucagon via its glycogenolytic properties and ultimately its gluconeogenic properties maintains the blood glucose
|
|
where is Preproinsulin synthesized?
|
in the rough endoplasmic reticulum of the beta cells in the pancreatic islets and is cleaved to form proinsulin
|
|
where does the cleavage of C Peptide occur in order to yield insulin?
|
Golgi apparatus
|
|
what is the best marker for endogenous insulin release?
|
C Peptide
|
|
T/F
Insulin normally has a biphasic release |
True
|
|
describe the biphasic release of insulin
|
there is first and immediate release of insulin from stored levels followed by a protracted release from the synthesis of new insulin
|
|
T/F
the immediate release of insulin is impaired in early diabetes. |
True
|
|
how is the defect of insulin release in early diabetes detected?
|
the defect is detected by infusing glucose and collecting insulin levels minutes apart and noting the impaired response
|
|
what is the only stimuli for insulin release that stimulates both phases?
|
HYPERglycemia stimulates both phases of insulin release
|
|
what are the stimuli for insulin release that just stimulate the immediate release?
|
GIP released once the gastric meal hits the duodenum
aminogenic stimulation by leucine and arginine caffeine sulfonylurea compounds hyperkalemia other hormones like gastrin, secretin, cholecystokinin |
|
what factors impair insulin release?
|
HYPOkalmeia and counteraction of many hormones: like gastrin, glucagon, GH, adrenocorticotrophic hormone, cortisol, catecholamines, somatostatin, and thyroxine.
|
|
describe the binding of insulin.
|
insulin binds to receptor sites on the membrane of the adipose and muslce
It activates tyrosine specific kinase, which: 1. activates protein synthesis 2. activates DNA synthesis 3. activates/inactivates enzymes in the mT |
|
what does insulin cause to happen to GLUT receptors?
|
translocation of GLUT from the Golgi apparatus to the plasma membrane to facilitate the uptake of glucose
|
|
where is GLUT 2 found?
|
insulin independent tissues like the liver and beta cells of islets
|
|
where is GLUT 4 found?
|
insulin dependent tissues like muscle and adipose
|
|
T/F
the number of insulin receptors in inversely proportional to the number of adipose cells |
true
obese individuals have less receptors and are slightly glucose intolerant |
|
what is hyperglycemia in DKA primarily the result of?
|
increased gluconeogenesis in the liver
|
|
what is the fuel for gluconeogenesis in DKA?
|
amino acids that would normally be taken up by the muscle but since insulin is not present alanine is converted to pyruvate which is a key substrate for gluconeogenesis
|
|
what are the fatty acids from DKA utilized for?
|
ketogenesis in the liver
|
|
what are two other key sources of glucose in DKA?
|
1. glucose that would have be utilized by the adipose and muscle in the presence of insulin
2. glycogenolysis due to the presence of glucagon and epinephrine |
|
what enhances glycogenolysis in the muscle?
|
epinephrine
|
|
what type of renal signs are caused by the hyperglycemia seen in DKA?
|
hyperglycemia in DKA results in glucouria when the renal threshold is saturated. This produces osmotic diuresis with subsequent loss of hypotonic fluid including sodium, potassium, phosphate, and water
|
|
In DKA, glycerol is the primarily used for?
|
a substrate for gluconeogenesis
|
|
what is glycerol used for in the presence of insulin?
|
substrate for triacylglycerol synthesis
|
|
T/F
in DKA you would expect an increase in the beta oxidation of fatty acids |
True
there is an increase in beta oxidation of fatty acids, since malonyl coA, the inhibitor of carnitine acyltransferase is not present. Recall that insulin enhanced fatty acid synthesis is responsible for production of malonyl CoA, therefor in the absence of insulin not only reduces fatty acid synthesis, but also increases beta-oxidation of fatty acids in the mT. One of the end products of the beta oxidation of fatty acids is acetyl CoA which is used for a substrate in ketogenesis |
|
T/F
in DKA you would expect a decrease in glycolysis |
True
in the absence of insulin and the presence of glucagon |
|
T/F
in DKA there is a decreased activation of capillary lipoprotein lipase |
true
since insulin, which is responsible for its synthesis is absent. This results in a build up of chylomicrons, and very low density lipoproteins and potential for severe hyperlipidemia Eruptive xanthomas and acute pancreatitis are two potential complications of hyperlipidemia |
|
T/F
in DKA there is a decrease in the breakdown of chylomicrons and VLDL. |
True
capillary lipoprotein lipase is decreased |
|
T/F
in DKA there is an increased activation of hormone sensitive lipase in the adipose by glucagon and epinephrine |
True
this increases the release of fatty acids and glycerol, the former (glucagon) used in ketogenesis and the later (epinephrine) a substrate for gluconeogenesis |
|
ketone bodies in DKA derive from acetyl cOA which is primarily derived from?
|
the beta oxidation of fatty acids
|
|
T/F
DKA is primarily seen in Type II diabetics |
False
DKA is primarily seen in Type I DM because there is no insulin produced |
|
T/F
there is enough insulin produced in type II DM to prevent DKA, but not enough to prevent HYPERglycemia |
True
|
|
is there an increase in beta oxidation of fatty acids in DKA?
|
yes, there is an increase in beta oxidation of fatty acids in DKA, since malonyl CoA, the inhibitor of carnitine acyltransferase is not present. Recall, that insulin enhanced fatty acid synthesis is responsible for the production of malonyl CoA therefore the absence of insulin not only reduces fatty acid synthesis, but also increases the beta oxidation of fatty acids in the mT.
One of the end products of beta oxidation of fatty acids is acetyl CoA which is used as a substrate for ketogenesis, which primarily occurs in the liver. |
|
what is the reaction for acetyl CoA > BHB?
|
Acetyl CoA > acetoaceto CoA > HMG CoA > AcAc > BHB
|
|
what is responsible for the fruity odor to the breath of a person in DKA?
|
AcAc breaks down into acetone
|
|
what results in an increased AG metabolic acidosis in DKA?
|
increased AcAc and BHB
|
|
patient presents with panhypopituitarism, what are total serum T4 and TSH?
|
decreased total serum T4
decreased TSH |
|
woman is taking OCPs, what would her total serum T4 and TSH be?
|
Increased Total Serum T4
Normal Serum TSH - increased TBG because of the OCPs |
|
Patient with normal thyroid exam who has nephrotic syndrome. what do their thyroid studies look like?
|
Decreased Total Serum T4
Normal Serum TSH - loss of TBG in the urine |
|
Patient has primary hypothyroidism. what do their thyroid studies look like?
|
decreased total T4
increased TSH |
|
Overweight patient with sinus tachycardia, systolic HTN, fine tremor. Thyroid gland not palpable. She says she is taking a "diet pill"
Thyroid studies? |
Decreased TSH
Increased Serum Total T4 - woman is taking excess thyroid hormone to lose weight |
|
T/F
T/F The combination of Hashimoto's thyroiditis and pernicious anemia has no causal relationship. |
False
they are both autoimmune diseases, hence they may occur together |
|
T/F
Antibodies against HCV indicate immunity to future exposure to the virus |
False
they indicate active disease no protective antibodies have been identified to date |
|
T/F
Yellow skin with white sclera is due to accumulation of retinoic acid in the skin |
False
b-carotenes are normally converted to retinoic acid in the intestine with the aid of thyroxine, hence hypothyroidism leads to an accumulation of b-carotenes not retinoic acid |
|
T/F
b-carotenemia may cause vitamin A toxicity |
Fasle
only an increase in retinoic acid can produce toxicity |
|
T/F
an elevated serum CK in primary hypothyroidism is secondary to proximal muscle myopathy |
True
|
|
T/F
Hypercholesterolemia in primary hypohthyroidism is secondary to reduced synthesis of LDL receptors |
True
|
|
T/F
Puffiness around the eyes in primary hypothyroidism is due to an increase in mucopolysaccharide deposition. |
True
|
|
T/F
Tinel's sign and Phalen's sign are used to diagnose median nerve entrapment. |
True
Tinel's sign" involves tapping over the median nerve Phalen's sign: compression of the nerve |
|
T/F
A schilling's test could still be performed on this patient even though they are taking B12. it would show reabsorption of radioactive B12 after administration of both IF and radioactive B12 |
true
|
|
T/F
HCV is the most common infection transmitted by blood transfusion. |
False
CMV is the most common |
|
T/F
HCV is the most common cause of post transfusion hepatitis |
True
|
|
T/F
Corticosteroids are essential in the treatment of chronic HCV |
False
corticosteroids are contraindicated in HCV a-INF is the treatment of choice |
|
T/F
Graves disease and Hashimoto's thyroiditis have thyroid stimulating immunoglobulins however they are stimulatory in Graves disease and inhibitory in Hashimoto's thyroiditis. |
True
|
|
T/F
total serum T4 levels are best used to follow patients being treated for hypothyroidism with levothyroxine. |
False
TSH is the best test and combined with free T4 |
|
what are the diagnostic criteria for DM?
|
1. FBS > 126 mg/dL
2. 2 hr. PG > 200 mg/dL during oral glucose test 3. Random glucose > 200 mg/dL with symptoms or hyperglycemic crisis 4. HbA1c > 6.5% |
|
what are the diagnostic criteria for Impaired Glucose tolerance?
|
1. FBS > 100 and < 126 mg/dL
2. 2 hr. PG > 140 and < 200 mg/dL 3. HbA1c 5.7-6.4% |
|
describe the pathogenesis behind TYPE I DM?
|
- absence of insulin secretion
- autoimmune/idiopathic - rapid onset of symptoms - insulin tx required to sustain life - HLA association - younger/thin patients |
|
describe the pathogenesis behind TYPE II DM.
|
- reduced insulin secretion or raised insulin
- NO HLA/autoimmune association - Insideous onset of symptoms - insulin tx not required to sustain life except in patients who fail OAD tx - older/obese patients |
|
which type of diabetes is ketoacidosis associated with?
|
type I DM
- they have NO insulin |
|
if your patient has NO C-peptide, what is that a diagnosis for?
|
Type I DM
|
|
what are frequent symptoms of Type II DM?
|
3 P's:
polyuria polydipsia polyphagia |
|
what are the acute complications of Diabetes?
|
1. HYPOglycemia (type I & 2)
- blood sugar < 50 mg/dL 2. DKA (type I) -absolute insulin deficiency with production of large amount of ketones 3. HYPERglycemia hyperosmolar state (type II DM) - marked elevation of blood sugar with severe dehydration |
|
what are the chronic complications of Diabetes?
|
Macrovascular:
1. heart attack 2. stroke 3. Peripheral vascular disease Microvascular 1. eye disease leading to blindess 2. kidney disease leading to kidney failure 3. neuropathy |
|
what are the guideline/goals in prevention of complications of DM?
|
1. HbA1c < 7.0%
2. LDL < 100 mg/dL (< 70 mg/dL in CVD hx) 3. BP < 130/80 mmHg |
|
describe what the HbA1C is.
|
Glycosylated hemoglobin
- irreversible binding of glucose with amino acids on the globulin component of Hb - accurate average level of BG for last 8-12 weeks - use as monitor to measure level of control of BG - Normal < 5.7% |
|
how are Biguanides used in the treatment of Type II DM?
|
decrease hepatic glucose production and increase insulin mediated peripheral glucose uptake
efficacy: decrease fasting plasma glucose 60-80 mg/dL reduce A1c: 1.5-2.0 % |
|
what drugs are in the Biguanides class of diabetic medication?
|
Metformin
|
|
who is Metformin contraindicated in?
|
patients with impaired renal function
NO Biguanides |
|
GLP-1 receptor analogues, Victoza, indicated in what disease?
|
Type II DM as an adjunct to diet and exercise
once daily SC administration |
|
what are the adverse drug reactions of GLP-1 analogues, Victoza?
|
nausea, vomiting, diarrhea, weight loss
|
|
when is Victoza, GLP-1 analogue, contraindicated?
|
h/o medullary thyroid cancer
|
|
what is considered to be one of the 5 highest risk medicines in the inpatient setting?
|
Insulin therapy
|
|
what are the rapid acting insulins?
|
Lispro
Aspart Glulisine |
|
what are the short acting insulins?
|
Regular human insulin
|
|
what are the intermediate acting insulins?
|
Human NPH
|
|
what are the long acting insulins?
|
Detemir
Glargine |
|
how do you initiate insulin therapy?
|
Empiric dosing (daily dose)
- Insulin analogues > Type 1: 0.5 u/kg/d > Type 2: 0.7-1.0 u/kg/d (obesity & exercise) - Give 50% Basal insulin - Give 50% Bolus insulin Split into 3 doses Adjust accordingly > carb counting |
|
why is insulin given at a higher dose to type II DM patients when initiating insulin therapy?
|
Type II doses are higher because there is an insulin resistance present.
|